(In thousands)
For the Three Months
Ended September 30, |
For the Nine Months
Ended September 30, | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Adjusted EBITDA: | ||||||||||||||||
Net loss | $ | (15,041 | ) | $ | (14,711 | ) | $ | (51,585 | ) | $ | (37,476 | ) | ||||
Add (deduct): | ||||||||||||||||
Interest expense, interest and dividend income and other expenses | 139 | 448 | 2,991 | 1,363 | ||||||||||||
Depreciation and amortization expense(1) | 1,909 | 816 | 5,716 | 2,304 | ||||||||||||
Income tax benefit | — | — | (559 | ) | — | |||||||||||
Amortization of lease intangible | 333 | — | 999 | — | ||||||||||||
Stock-based compensation (2) | 5,113 | 2,266 | 14,048 | 4,747 | ||||||||||||
Charitable contribution of common stock | 987 | 1,157 | 2,272 | 1,157 | ||||||||||||
Income from unconsolidated joint venture | (297 | ) | — | (600 | ) | — | ||||||||||
Acquisition and other (3) | 42 | — | (1,242 | ) | — | |||||||||||
Impairment of assets | 325 | — | 444 | — | ||||||||||||
Adjusted EBITDA | $ | (6,490 | ) | $ | (10,024 | ) | $ | (27,516 | ) | $ | (27,905 | ) |